Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 25
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pulm Pharmacol Ther ; 54: 60-67, 2019 02.
Artigo em Inglês | MEDLINE | ID: mdl-30502381

RESUMO

INTRODUCTION: Mucoactive agent, erdosteine, besides mucolytic activity, is characterized by many other pharmacodynamic properties which could be beneficial in the management of inflammatory conditions. BACKGROUND: Using guinea pig experimental model of allergic inflammation, we evaluated the ability of erdosteine to modulate airway defence mechanisms and inflammation after 10 days (10 mg/kg/day) administration. METHODS: In vivo changes in specific airway resistance and amplitude of tracheal contraction were estimated to evaluate the bronchodilatory effect. The sensitivity of chemically induced cough reflex was estimated via in vivo method. The ciliary beat frequency assessed on brushed tracheal cells was used as an indicator of the mucociliary clearance rate. The concentrations of the inflammatory cytokines IL-4, IL-5, IL-13 and IL-10 were measured in BALF using multiplex detecting method. RESULTS: Our data show that 10 days erdosteine administration resulted in bronchodilation and stimulation of ciliary beat frequency. Erdosteine did not affect the parameters of chemically induced cough reflex. Erdosteine demonstrated the modest decline in inflammatory cytokines IL-5, IL-13 and an increase in the concentration of IL-10, which is a potent regulator of inflammatory responses and plays a critical role in controlling allergic airway inflammation. CONCLUSION: In summary, we can state, that erdosteine is multi-action drug and it seems to have many beneficial and complementary effect in the management of chronic inflammatory airway diseases complicated by viscous mucus.


Assuntos
Broncodilatadores/farmacologia , Citocinas/imunologia , Inflamação/tratamento farmacológico , Tioglicolatos/farmacologia , Tiofenos/farmacologia , Animais , Líquido da Lavagem Broncoalveolar/imunologia , Tosse/prevenção & controle , Modelos Animais de Doenças , Expectorantes/farmacologia , Cobaias , Inflamação/imunologia , Masculino , Depuração Mucociliar
2.
Adv Exp Med Biol ; 1023: 1-10, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-28730380

RESUMO

Erdosteine as a mucolytic agent that decreases mucus viscosity and facilitates mucus expulsion from the airways by cough or ciliary movement. Our objective was to determine whether erdosteine can directly contribute to mucus clearance. We addressed the issue by monitoring acute and chronic effects of erdosteine on ciliary beat frequency (CBF), cough sensitivity, and airway smooth muscle reactivity. The experiments were performed in healthy guinea pigs. Erdosteine (10 mg/kg) was administrated orally in a single dose or daily through 7 days. The cough reflex and specific airway resistance were evaluated in vivo. The CBF in tracheal brushed samples and the contractile response of tracheal smooth muscle stripes to bronchoconstrictive mediators were evaluated in vitro. We found that neither acute nor chronic erdosteine treatment had a significant effect on cough sensitivity and airway reactivity. However, in the vitro condition, erdosteine increased CBF and reduced tracheal smooth muscle contractility; the effects were more pronounced after chronic treatment. We conclude that erdosteine may directly contribute to mucus clearance by CBF stimulation. Although erdosteine has no effect on cough reflex sensitivity, its mild bronchodilator and mucolytic properties may promote effective cough.


Assuntos
Cílios/patologia , Tosse/tratamento farmacológico , Hipersensibilidade Respiratória/tratamento farmacológico , Tioglicolatos/administração & dosagem , Tioglicolatos/uso terapêutico , Tiofenos/administração & dosagem , Tiofenos/uso terapêutico , Administração Oral , Animais , Cílios/efeitos dos fármacos , Ácido Cítrico , Tosse/fisiopatologia , Relação Dose-Resposta a Droga , Cobaias , Histamina , Masculino , Reflexo/efeitos dos fármacos , Hipersensibilidade Respiratória/fisiopatologia , Traqueia/efeitos dos fármacos , Traqueia/fisiopatologia
3.
Adv Exp Med Biol ; 921: 27-35, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27369295

RESUMO

Overproduction of mucus is a hallmark of asthma. The aim of this study was to identify potentially effective therapies for removing excess mucus. The role of voltage-gated (Kir 6.1, KCa 1.1) and store-operated ion channels (SOC, CRAC) in respiratory cilia, relating to the tracheal ciliary beat frequency (CBF), was compared under the physiological and allergic airway conditions. Ex vivo experiments were designed to test the local effects of Kir 6.1, KCa 1.1 and CRAC ion channel modulators in a concentration-dependent manner on the CBF. Cilia, obtained with the brushing method, were monitored by a high-speed video camera and analyzed with ciliary analysis software. In natural conditions, a Kir 6.1 opener accelerated CBF, while CRAC blocker slowed it in a concentration-dependent manner. In allergic inflammation, the effect of Kir 6.1 opener was insignificant, with a tendency to decrease CBF. A cilio-inhibitory effect of a CRAC blocker, while gently reduced by allergic inflammation, remained significant. A KCa 1.1 opener turned out to significantly enhance the CBF under the allergic OVA-sensitized conditions. We conclude that optimally attuned concentration of KCa 1.1 openers or special types of bimodal SOC channel blockers, potentially given by inhalation, might benefit asthma.


Assuntos
Asma/patologia , Cílios/fisiologia , Inflamação/patologia , Canais Iônicos/antagonistas & inibidores , Mucosa Respiratória/fisiologia , Traqueia/fisiologia , Animais , Asma/induzido quimicamente , Asma/tratamento farmacológico , Asma/metabolismo , Bloqueadores dos Canais de Cálcio/farmacologia , Cílios/efeitos dos fármacos , Modelos Animais de Doenças , Cobaias , Hipersensibilidade/tratamento farmacológico , Hipersensibilidade/etiologia , Hipersensibilidade/metabolismo , Hipersensibilidade/patologia , Inflamação/induzido quimicamente , Inflamação/tratamento farmacológico , Inflamação/metabolismo , Canais Iônicos/metabolismo , Masculino , Ovalbumina/toxicidade , Mucosa Respiratória/efeitos dos fármacos , Traqueia/efeitos dos fármacos
4.
Adv Exp Med Biol ; 935: 25-34, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27329088

RESUMO

The aim of this study was to determinate bronchodilator, antitussive, and ciliomodulatory activity of inhaled combination therapy with budesonide and salmeterol, and to correlate the results with the anti-inflammatory effect. The experiments were performed using two models of allergic inflammation (21 and 28 days long sensitization with ovalbumine) in guinea pigs. The animals were treated daily by aerosols of budesonide (1 mM), salmeterol (0.17 mM), and a half-dose combination of the two drugs. Antitussive and bronchodilator activities were evaluated in vivo. The ciliary beat frequency (CBF) was assessed in vitro in tracheal brushed samples, and inflammatory cytokines (IL-4, IL-5, IL-13, GM-CSF, and TNF-α) were determined in bronchoalveolar lavage fluid (BALF). We found that the combination therapy significantly decreased the number of cough efforts, airway reactivity, and the level of inflammatory cytokines in both models of allergic asthma. Three weeks long sensitization led to an increase in CBF and all three therapeutic approaches have shown a ciliostimulatory effect in order: salmeterol < budesonid < combination therapy. Four weeks long ovalbumine sensitization, on the other hand, decreased the CBF, increased IL-5, and decreased IL-13. In this case, only the combination therapy was able to stimulate the CBF. We conclude that a half-dose combination therapy of budesonide and salmeterol shows comparable antitussive, bronchodilator, and the anti-inflammatory effect to a full dose therapy with budesonide alone, but had a more pronounced stimulatory effect on the CBF.


Assuntos
Asma/tratamento farmacológico , Broncodilatadores/farmacologia , Budesonida/farmacologia , Tosse/tratamento farmacológico , Inflamação/tratamento farmacológico , Xinafoato de Salmeterol/farmacologia , Animais , Asma/induzido quimicamente , Asma/fisiopatologia , Cílios/efeitos dos fármacos , Cílios/fisiologia , Tosse/induzido quimicamente , Tosse/fisiopatologia , Modelos Animais de Doenças , Sinergismo Farmacológico , Quimioterapia Combinada , Cobaias , Inflamação/induzido quimicamente , Inflamação/fisiopatologia , Masculino , Ovalbumina/toxicidade
5.
Adv Exp Med Biol ; 921: 71-80, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27161110

RESUMO

Expression of voltage-gated sodium channels (Nav) takes place in the airways and the role of Nav1.7 and Nav1.8 in the control of airway's defense reflexes has been confirmed. The activation of Nav channels is crucial for cough initiation and airway smooth muscle reactivity, but it is unknown whether these channels regulate ciliary beating. This study evaluated the involvement of Nav1.7 and Nav1.8 channels in the airway defense mechanisms using their pharmacological blockers in healthy guinea pigs and in the experimental allergic asthma model. Asthma was modeled by ovalbumin sensitization over a period of 21 days. Blockade of Nav1.7 channels significantly decreased airway smooth muscle reactivity in vivo, the number of cough efforts, and the cilia beat frequency in healthy animals. In the allergic asthma model, blockade of Nav1.8 efficiently relieved symptoms of asthma, without adversely affecting cilia beat frequency. The study demonstrates that Nav1.8 channel antagonism has a potential to alleviate cough and bronchial hyperreactivity in asthma.


Assuntos
Asma/patologia , Cílios/fisiologia , Tosse/tratamento farmacológico , Músculo Liso/fisiologia , Mucosa Respiratória/fisiologia , Canais de Sódio Disparados por Voltagem/química , Animais , Asma/induzido quimicamente , Asma/tratamento farmacológico , Asma/metabolismo , Cílios/efeitos dos fármacos , Tosse/induzido quimicamente , Tosse/metabolismo , Modelos Animais de Doenças , Cobaias , Hipersensibilidade/tratamento farmacológico , Hipersensibilidade/etiologia , Hipersensibilidade/metabolismo , Hipersensibilidade/patologia , Masculino , Músculo Liso/efeitos dos fármacos , Ovalbumina/toxicidade , Mucosa Respiratória/efeitos dos fármacos , Bloqueadores dos Canais de Sódio/farmacologia , Canais de Sódio Disparados por Voltagem/metabolismo
6.
Adv Exp Med Biol ; 838: 27-34, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25315622

RESUMO

Our previous studies show that provinol, a polyphenolic compound, has anti-inflammatory activity during allergic inflammation. In the present study we investigated the effects of provinol and its combinations with clinically used antiasthmatics: budesonide or theophylline on airway defense mechanisms during experimental allergic asthma. Separate groups of guinea pigs were treated during the course of 21-day ovalbumin sensitization with provinol (20 mg/kg/day, p.o.), or budesonide (1 mM by inhalation), or theophylline (10 mg/kg/day, i.p.), and with a half-dose combination of provinol+budesonide or provinol+theophylline. Airways defense mechanisms: cough reflex and specific airway resistance (sRaw) were evaluated in vivo. Tracheal smooth muscle reactivity and mucociliary clearance were examined in vitro. The findings were that provinol caused significant decreases in sRaw and in tracheal smooth muscle contractility, a suppression of cough reflex, and positively modulated ciliary beat frequency. The bronchodilatory and antitussive effects of provinol were comparable with those of budesonide and theophylline. Provinol given as add-on treatment significantly potentiated the effects of budesonide or theophylline, although the doses of each were halved. We conclude that provinol not only has bronchodilatory and antitussive effects, but also potentiates similar effects exerted by budesonide and theophylline.


Assuntos
Antiasmáticos/farmacologia , Antitussígenos/farmacologia , Asma/tratamento farmacológico , Broncodilatadores/farmacologia , Pulmão/efeitos dos fármacos , Polifenóis/farmacologia , Administração por Inalação , Administração Oral , Resistência das Vias Respiratórias/efeitos dos fármacos , Animais , Asma/induzido quimicamente , Asma/fisiopatologia , Budesonida/farmacologia , Sinergismo Farmacológico , Quimioterapia Combinada , Cobaias , Injeções Intraperitoneais , Pulmão/fisiopatologia , Masculino , Músculo Liso/efeitos dos fármacos , Ovalbumina , Teofilina/farmacologia , Técnicas de Cultura de Tecidos
7.
Adv Exp Med Biol ; 838: 35-45, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25315623

RESUMO

High-conductive calcium-sensitive potassium channels (BK+Ca) and ATP-sensitive potassium (K+ATP) channels play a significant role in the airway smooth muscle cell and goblet cell function, and cytokine production. The present study evaluated the therapeutic potential of BK+Ca and K+ATP openers, NS 1619 and pinacidil, respectively, in an experimental model of allergic inflammation. Airway allergic inflammation was induced with ovalbumine in guinea pigs during 21 days, which was followed by a 14-day treatment with BK+Ca and K+ATP openers. The outcome measures were airway smooth muscle cells reactivity in vivo and in vitro, cilia beating frequency and the level of exhaled NO (ENO), and the level of pro-inflammatory cytokines in the plasma and bronchoalveolar lavage fluid. The openers of both channels decreased airway smooth muscle cells reactivity, cilia beating frequency, and cytokine levels in the serum. Furthermore, NS1619 reduced ENO and inflammatory cells infiltration. The findings confirmed the presence of beneficial effects of BK+Ca and K+ATP openers on airway defence mechanisms. Although both openers dampened pro-inflammatory cytokines and mast cells infiltration, an evident anti-inflammatory effect was provided only by NS1619. Therefore, we conclude that particularly BK+Ca channels represent a promising new drug target in treatment of airway's allergic inflammation.


Assuntos
Resistência das Vias Respiratórias/efeitos dos fármacos , Benzimidazóis/farmacologia , Hiper-Reatividade Brônquica/tratamento farmacológico , Canais KATP/agonistas , Canais de Potássio Ativados por Cálcio de Condutância Alta/agonistas , Moduladores de Transporte de Membrana/farmacologia , Administração por Inalação , Animais , Hiper-Reatividade Brônquica/induzido quimicamente , Hiper-Reatividade Brônquica/metabolismo , Hiper-Reatividade Brônquica/fisiopatologia , Líquido da Lavagem Broncoalveolar/química , Cílios/efeitos dos fármacos , Citocinas/biossíntese , Citocinas/metabolismo , Expiração , Cobaias , Canais KATP/metabolismo , Canais de Potássio Ativados por Cálcio de Condutância Alta/metabolismo , Pulmão/efeitos dos fármacos , Pulmão/metabolismo , Pulmão/fisiopatologia , Masculino , Músculo Liso/efeitos dos fármacos , Óxido Nítrico/biossíntese , Ovalbumina , Pinacidil/farmacologia , Pletismografia Total , Técnicas de Cultura de Tecidos
8.
Int J Biol Macromol ; 69: 214-21, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24875316

RESUMO

A dark brown polymeric complex was isolated from flowering parts of medicinal plant Arnica montana L. by hot alkaline extraction followed by neutralization and multi-step extractions with organic solvents. It was recovered in 5.7% yield, on GPC showed two peaks of molecular mass of 9 and 3.5kDa. The compositional analyses of Arnica complex revealed the presence of carbohydrates (26%), uronic acids (12%), phenolics (1.25mM or 213mg of GAE/1g), and low protein content (∼1%). The carbohydrate moiety was rich mainly in rhamnogalacturonan and arabinogalactan. The antitussive tests showed the reduction of the cough efforts by Arnica complex, however, its total antitussive effect was lower compared with that of codeine, the strongest antitussive agent. The bronchodilatory activity of Arnica complex was similar to salbutamol, a classic antiasthmatic drug, and was confirmed by significantly decreased values of specific airways resistance in vivo and by considerably attenuated the amplitude of acetylcholine and histamine-induced contractions in vitro. Arnica complex did not show any cytotoxic effect on mouse fibroblast cultures and human lung cells, up to the dose of 500µg/mL.


Assuntos
Antitussígenos/farmacologia , Arnica/química , Extratos Vegetais/farmacologia , Animais , Antitussígenos/química , Antitussígenos/isolamento & purificação , Antitussígenos/uso terapêutico , Antitussígenos/toxicidade , Linhagem Celular , Ácido Cítrico/efeitos adversos , Tosse/induzido quimicamente , Tosse/tratamento farmacológico , Cobaias , Humanos , Masculino , Camundongos , Músculo Liso/efeitos dos fármacos , Músculo Liso/fisiopatologia , Extratos Vegetais/química , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/uso terapêutico , Extratos Vegetais/toxicidade , Reflexo/efeitos dos fármacos , Sistema Respiratório/efeitos dos fármacos
9.
Int J Biol Macromol ; 52: 192-7, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23041666

RESUMO

Polyphenolic-polysaccharide-protein complex has been isolated from flowers of Solidago canadensis L. by hot alkaline extraction procedure. Compositional analyses of S canadensis complex revealed the presence of carbohydrates (43 wt%), protein (27 wt%), phenolics (12 wt%), uronic acids (10 wt%) and inorganic material (8 wt%). The carbohydrate part was rich in neutral sugars (81 wt%) while uronids were determined in lower amount (19 wt%). Monosaccharide analysis of carbohydrate part revealed the presence of five main sugar components, i.e. rhamnose (~23 wt%), arabinose (~20 wt%), uronic acids (~19 wt%), galactose (~17 wt%) and glucose (~14 wt%), and indicated thus the presence of rhamnogalacturonan and arabinogalactan in S. canadensis complex. HPLC analysis of complex showed one single peak of molecule mass at 11.2 kDa. Antitussive activity tests, performed in three doses of Solidago complex, showed the reduction of the number of cough efforts in the dose-dependent manner. Higher doses (50 and 75 mg/kg b.w.) were shown to be by 15 and 20% more effective than that of lower one (25mg/kg b.w.). However, the antitussive effect of the highest dose (75 mg/kg b.w.) was by 10% lower in comparison with that of codeine, the strongest antitussive agent. Besides, the highest dose of the complex (75 mg/kg b.w.) significantly decreased values of specific airways resistance and their effect remained longer as that of salbutamol, a representative of classic antiasthmatic drugs.


Assuntos
Resistência das Vias Respiratórias/efeitos dos fármacos , Antitussígenos , Broncodilatadores/farmacologia , Tosse/tratamento farmacológico , Extratos Vegetais/farmacologia , Solidago/química , Albuterol/química , Animais , Antitussígenos/química , Antitussígenos/farmacologia , Broncodilatadores/química , Codeína/química , Codeína/farmacologia , Relação Dose-Resposta a Droga , Cobaias , Extratos Vegetais/química
10.
Adv Exp Med Biol ; 756: 49-55, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-22836618

RESUMO

The aim of the study was to prepare and evaluate the experimental model of allergic asthma. Changes in chough reflex, bronchoconstriction and the degree of inflammation were studied in ovalbumin (OVA) sensitized guinea pigs after 0, 7, 14, 21 days of exposure. The cough reflex was induced by citric acid inhalation in conscious animals in a double chamber body plethysmograph. Tracheal smooth muscle reactivity was assessed by examining the in vitro response to histamine (H) (10(-8)-10(-3) mol/l) and in vivo to H nebulization (10(-6) mol/l). BALF levels of IL-4, IL-5 and the eosinophil count were used as parameters of airway inflammation. After 7 days of OVA sensitization, there was an increase in tracheal smooth muscle contractility in vitro to cumulative concentration of H and an increase in cough parameters. After 14 days of OVA sensitization, there was a further increase in tracheal smooth muscle contractility to H, an increase in airway resistance, and a small increase in cough parameters. After 21 day of OVA sensitization, cough parameters were significantly reduced, airway resistance after H inhalation was increased, and there were significant increases in IL-4, IL-5, and eosinophils in BALF. In conclusion, progress in asthmatic inflammation during 21-day OVA sensitization caused a gradual increase in inflammatory mediators, a decline in cough reflex, and enhanced bronchoconstriction. This experimental model of allergic asthma can be used for pharmacological modulations of defense reflexes and inflammation.


Assuntos
Asma , Broncoconstrição , Modelos Animais de Doenças , Traqueia/imunologia , Resistência das Vias Respiratórias , Animais , Asma/induzido quimicamente , Asma/imunologia , Asma/fisiopatologia , Líquido da Lavagem Broncoalveolar/imunologia , Ácido Cítrico , Tosse/induzido quimicamente , Eosinófilos/imunologia , Cobaias , Histamina/farmacologia , Interleucina-4/análise , Interleucina-5/análise , Masculino , Contração Muscular/efeitos dos fármacos , Músculo Liso/fisiopatologia , Ovalbumina , Reflexo , Traqueia/fisiopatologia
11.
Adv Exp Med Biol ; 756: 39-48, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-22836617

RESUMO

Calcium release-activated calcium channels (CRAC) play unambiguous role in secretory functions of mast cells, T cells, and eosinophils. Less knowledge exists about the role of CRAC, widely distributed in airway smooth muscle (ASM) cells, in airway contractility. The presented study seeks to determine the possible participation of CRAC in ASM-based inflammatory airway disorders in guinea pigs. The acute and long-term administration (14 days) of the CRAC antagonist 3-fluoropyridine-4-carboxylic acid was used to examine the ASM contractility and associated reflexes in the guinea pig model of allergic airway inflammation by the following methods: (i) evaluation of specific airway resistance in vivo; (ii) evaluation of the contractile response of isolated ASM strips in vitro; and (iii) citric acid-induced cough reflex; (iv) measurement of exhaled NO levels (E(NO)). Allergic airway inflammation was induced by repetitive exposure of guinea pigs to ovalbumin (10(-6) M). The CRAC antagonist administered in a single dose to guinea pigs with confirmed allergic inflammation significantly reduced the cough response and the airway resistance, which corresponded with the findings in vitro. Long-term application of the CRAC antagonist had more strongly expressed effects. The results confirm the role of CRAC in the pathophysiology of experimental animal asthma and have a potential meaning for anti-asthma therapy.


Assuntos
Asma/tratamento farmacológico , Bloqueadores dos Canais de Cálcio/farmacologia , Canais de Cálcio/metabolismo , Hipersensibilidade/tratamento farmacológico , Ácidos Isonicotínicos/farmacologia , Contração Muscular , Miócitos de Músculo Liso/fisiologia , Animais , Antiasmáticos/farmacologia , Cálcio/metabolismo , Tosse , Retículo Endoplasmático/metabolismo , Eosinófilos/metabolismo , Cobaias , Humanos , Masculino , Mastócitos/metabolismo , Contração Muscular/efeitos dos fármacos , Miócitos de Músculo Liso/efeitos dos fármacos , Óxido Nítrico/análise , Ovalbumina/administração & dosagem , Sistema Respiratório/efeitos dos fármacos , Sistema Respiratório/imunologia , Linfócitos T/metabolismo
12.
Int J Biol Macromol ; 51(5): 794-9, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22829057

RESUMO

A high molecular mass polysaccharide-polyphenolic conjugate has been isolated from flowering parts of Lythrum salicaria by hot alkaline extraction. Its chemical analysis revealed 74% of carbohydrates and 17% of phenolics. Compositional analysis of carbohydrate part showed a high GalA content (49%), Rha (25%), Gal (13%) and Ara (9%) residues, and indicated thus rhamnogalacturonan associated with arabinogalactan in Lythrum conjugate. Antitussive activity tests, performed in three doses of Lythrum conjugate - 25, 50 and 75 mg/kg of animal body weight, showed the reduction of the number of cough efforts even 5h after administration. However, their antitussive effects were lower in comparison with that of codeine, the strongest narcotic antitussive agent. The tests evaluating the influence of different doses on airways smooth muscle reactivity revealed more significant effect of Lythrum conjugate in comparison with that of salbutamol, a commercial bronchodilator used in a clinical practice. Measurements of specific airway resistance pointed at both, the dose-dependent bronchodilatory activity and possible participation of bronchodilation on antitussive effect of Lythrum conjugate. This study represents the first sight into pharmacodynamic properties of Lythrum polysaccharide-polyphenolic glycoconjugate.


Assuntos
Antitussígenos/química , Antitussígenos/farmacologia , Broncodilatadores/química , Broncodilatadores/farmacologia , Lythrum/química , Polifenóis/química , Polissacarídeos/química , Animais , Antitussígenos/uso terapêutico , Broncodilatadores/uso terapêutico , Tosse/tratamento farmacológico , Cobaias , Masculino , Músculo Liso/efeitos dos fármacos , Músculo Liso/fisiologia , Sistema Respiratório/efeitos dos fármacos
13.
Bratisl Lek Listy ; 112(12): 670-5, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22372330

RESUMO

AIM: The presented studies were aimed on experimental confirmation of Althaea officinalis polysaccharide rhamnogalacturonan antitussive effect and its changes in conditions of allergic inflammation. METHODS: We have tested whether rhamnogalacturonan inhibits cough reflex and modulates airways reactivity of guinea pigs in vivo. The cough in guinea pigs was induced by 0.3 M citric acid (CA) aerosol for 3 min interval, in which total number of cough efforts (sudden enhancement of expiratory flow accompanied by cough movement and sound) was counted. Specific airway resistance and its changes induced by citric acid aerosol were considered as an indicator of the in vivo reactivity changes. RESULTS: 1) Althaea officinalis polysaccharide rhamnogalacturonan dose- dependently inhibits cough reflex in unsensitized guinea pigs. Simultaneously, plant polysaccharide shortened the duration of antitussive effect when it was been tested in inflammatory conditions. 2) Rhamnogalacturonan did not influence airways reactivity in vivo conditions expressed as specific resistance values neither sensitized nor unsensitized groups of animals. 3) The antitussive activity of codeine (dose 10 mg.kg(-1) b.w. orally) tested under the same condition was comparable to higher dose of rhamnogalacturonan in unsensitized animals. 4) The characteristic cellular pattern of allergic airways inflammation was confirmed by histopathological investigations. CONCLUSION: Rhamnogalacturonan isolated from Althaea officinalis mucilage possesses very high cough suppressive effect in guinea pigs test system, which is shortened in conditions of experimentally induced airways allergic inflammation (Tab. 1, Fig. 4, Ref. 25). Full Text in free PDF www.bmj.sk.


Assuntos
Althaea , Antitussígenos/farmacologia , Hiper-Reatividade Brônquica/fisiopatologia , Tosse/fisiopatologia , Pulmão/patologia , Extratos Vegetais/farmacologia , Polissacarídeos/farmacologia , Traqueia/patologia , Resistência das Vias Respiratórias , Animais , Hiper-Reatividade Brônquica/patologia , Relação Dose-Resposta a Droga , Cobaias , Inflamação , Ovalbumina/imunologia , Reflexo/efeitos dos fármacos
14.
Biomed Pharmacother ; 2010 Oct 23.
Artigo em Inglês | MEDLINE | ID: mdl-21115321

RESUMO

The Publisher regrets that this article is an accidental duplication of an article that has already been published, http://dx.doi.org/10.1016/j.bionut.2010.09.002. The duplicate article has therefore been withdrawn.

15.
Int J Biol Macromol ; 47(4): 508-13, 2010 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-20670644

RESUMO

A crude polysaccharide composed of uronic acids (32%), arabinose (26%), glucose (15%), galactose (11%), rhamnose (7%), mannose (5%), xylose (4%) and small amount of fucose residues has been isolated from the leaves of Opilia celtidifolia by boiled water extraction. Chemical analyses of Opilia polysaccharide revealed the prevalence of a pectin material with high arabinose and galacturonic acid contents. Opilia polysaccharide showed significant biological effects on chemically induced cough reflex and reactivity of airways smooth muscle in vitro and in vivo conditions in guinea pigs test system. Tests confirmed the dose-dependent cough-suppressive effect of Opilia polysaccharide comparable with activity of centrally acting codeine. Further, the bronchodilatory tests resulted in significant decrease in the values of specific airway resistance, which is very sensitive predictor of airway smooth muscle reactivity in vivo conditions regardless of bronchoconstricting mechanism. The results of in vitro experiments confirmed not only the bronchodilatory effect Opilia polysaccharide but revealed that its bronchodilatory mechanism is partially accompanied with enhanced NO production.


Assuntos
Antitussígenos/farmacologia , Broncodilatadores/farmacologia , Óxido Nítrico/metabolismo , Polissacarídeos/farmacologia , Santalaceae/química , Animais , Antitussígenos/uso terapêutico , Broncoconstrição/efeitos dos fármacos , Tosse/tratamento farmacológico , Tosse/fisiopatologia , Relação Dose-Resposta a Droga , Cobaias , Espectroscopia de Ressonância Magnética , Contração Muscular/efeitos dos fármacos , Músculo Liso/efeitos dos fármacos , Músculo Liso/fisiopatologia , Espectroscopia de Infravermelho com Transformada de Fourier
16.
Bratisl Lek Listy ; 110(8): 454-8, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19750980

RESUMO

BACKGROUND: The anti-inflammatory, anti-allergic, antioxidant properties of flavonoids are known in the respiratory tract. We are interested in the role of Provinol during an allergic inflammation of the airway. OBJECTIVES: The aim of this study was to examine the influence of an acute administration of Provinol on tracheal smooth muscle reactivity in guinea pigs and to assess the involvement of nitric oxide in the mechanism of Provinol action. METHODS: This experiment was performed 14 days after the sensitization of animals by ovalbumin. In vivo, the specific airway conductance, as a tracheal smooth muscle reactivity parameter in response to bronchoconstrictor histamine, was evaluated after peroral administration of Provinol alone or together with L-NAME (N(omega)-nitro-L-arginine methyl ester). In vitro, Provinol alone or in combination with L-NAME were added into an organ baths before the supplement of direct bronchoconstrictor histamine, acetylcholine and the allergen ovalbumin in rising concentrations. The amplitude of the tracheal smooth muscle contraction, as a tracheal smooth muscle reactivity parameter in response to histamine, acetylcholine and ovalbumin was evaluated. RESULTS: Our results showed that a Provinol has significant bronchodilatory activities both in vivo and in vitro. CONCLUSION: Provinol alleviated the contraction of tracheal smooth muscle in guinea pigs sumin. Nitric oxide plays an important role in the mechanism of Provinol action (Fig. 2, Ref. 28n.(Fig. 2, Ref. 28).


Assuntos
Hiper-Reatividade Brônquica/tratamento farmacológico , Flavonoides/uso terapêutico , Fenóis/uso terapêutico , Alérgenos , Animais , Hiper-Reatividade Brônquica/fisiopatologia , Cobaias , Contração Muscular/efeitos dos fármacos , Ovalbumina/imunologia , Polifenóis , Traqueia/efeitos dos fármacos , Traqueia/fisiopatologia , Vinho/análise
17.
Bratisl Lek Listy ; 110(5): 269-75, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19507659

RESUMO

BACKGROUND: The ATP-sensitive potassium ion channels (K+ATP) are widely expressed on airway sensory nerves that mediate cough and other protective reflexes; dependent on airways smooth muscles (ASM) reactivity. OBJECTIVE: The study was conducted to determine the involvement of K+ATP in airway sensory nerves activity of different animal species. METHODS: In this study we have evaluated the cough reflex inhibiting potential and modulation of ASM reactivity in vitro, by K+ATP opener-pinacidil in guinea pig and cats. The cough in guinea pig was induced by administration, in cats by mechanical stimulation of the airways. ASM reactivity was tested by organ tissue both method of 0.3 M citric acid aerosol at 3 min interval. RESULTS: 1) Pinacidil inhibits cough reflex in guinea pigs which was antagonized when pre-treated with K+ATP blocker glibenclamide. 2) Pinacidil exhibited antitussive activity in cats comparable to codeine and was noticeably higher than dropropizine effects. 3) ASM reactivity was significantly abolished by pinacidil and almost completely antagonized by glibenclamide in guinea pigs. 4) Pinacidil significantly attenuated ASM contraction in cats only in highest concentrations of contractile mediators. CONCLUSION: K+ATP may be involved in mechanisms of cough reflex, likewise in antitussive activity of several more agents and also on defence reflexes dependent on ASM reactivity in different animal species such as guinea pigs and cats (Fig. 8, Ref. 20). Full Text (Free, PDF) www.bmj.sk.


Assuntos
Tosse , Canais KATP/metabolismo , Reflexo/efeitos dos fármacos , Animais , Antitussígenos/farmacologia , Gatos , Ácido Cítrico , Tosse/etiologia , Feminino , Glibureto/farmacologia , Cobaias , Canais KATP/agonistas , Masculino , Contração Muscular/efeitos dos fármacos , Músculo Liso/efeitos dos fármacos , Estimulação Física , Pinacidil/farmacologia , Bloqueadores dos Canais de Potássio/farmacologia , Canais de Potássio/efeitos dos fármacos , Propilenoglicóis/farmacologia , Traqueia
18.
Int J Biol Macromol ; 45(1): 27-32, 2009 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-19447256

RESUMO

The rhamnogalacturonan, isolated from the roots of medicinal plant Althaea officinalis L., showed various biological effects on the citric acid-induced cough reflex and reactivity of airways smooth muscle in vitro and in vivo conditions. It possessed dose-dependent cough suppression effect comparable with opioid agonist codeine. However, reactivity of the airways smooth muscle, measured in vitro as well as in vivo conditions was not significantly affected by rhamnogalacturonan and thus bronchodilatory activity did not participate in the cough suppression effect of polysaccharide tested. Moreover, the cough suppression effect of the polymer was not significantly modified by pretreatment of K(+)(ATP) ion channels with selective antagonist and therefore activation of this type of ion channels is not involved in the mechanism of rhamnogalacturonan cough suppressive ability. On the contrary, pretreatment of animals with selective 5-HT(2) receptors antagonist significantly decreased rhamnogalacturonan antitussive efficacy. From this point of view it seems that the cough suppression effect of the polymer is associated with the serotonergic 5-HT(2) receptor's function.


Assuntos
Althaea/química , Antitussígenos/farmacologia , Pectinas/isolamento & purificação , Pectinas/farmacologia , Animais , Relação Dose-Resposta a Droga , Cobaias , Músculo Liso Vascular/efeitos dos fármacos
19.
Int J Biol Macromol ; 44(3): 236-9, 2009 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-19150368

RESUMO

From the leaves of popular Malian medicinal plants Trichilia emetica (TE) and Opilia celtidifolia (OC), and fruits of Crossopteryx febrifuga (CF) water and water-ethanol soluble polysaccharide materials were isolated. The results of chemical analysis of the crude polysaccharides showed the dominance of the arabinogalactan ( approximately 54%) and the rhamnogalacturonan ( approximately 30%) in T. emetica leaves, the arabinogalactan ( approximately 60%), the rhamnogalacturonan ( approximately 14%) and the glucuronoxylan ( approximately 14%) in O. celtidifolia leaves, and pectic type of polysaccharides ( approximately 75%) with a lower content of the arabinogalactan ( approximately 17%) in C. febrifuga fruits. The plant polysaccharides showed various biological effects on the citric acid-induced cough reflex and reactivity of airways smooth muscle in vivo conditions. T. emetica and O. celtidifolia polysaccharides possessed significant cough-suppressive effect on chemically induced cough. Furthermore, values of specific airways resistance pointed on bronchodilatory property of polysaccharides isolated from O. celtidifolia. However, the crude extract from C. febrifuga in the same dose as T. emetica and O. celtidifolia did not influence the experimentally induced cough as well as reactivity of airways smooth muscle despite of the fact that the water-ethanol extract is recommended for cough therapy in Mali in the form of syrup.


Assuntos
Antitussígenos/isolamento & purificação , Antitussígenos/farmacologia , Plantas Medicinais/química , Polissacarídeos/isolamento & purificação , Polissacarídeos/farmacologia , Administração Oral , Resistência das Vias Respiratórias/efeitos dos fármacos , Animais , Antitussígenos/administração & dosagem , Antitussígenos/uso terapêutico , Tosse/induzido quimicamente , Tosse/tratamento farmacológico , Tosse/fisiopatologia , Avaliação Pré-Clínica de Medicamentos , Cobaias , Mali , Meliaceae/química , Monossacarídeos/análise , Fitoterapia , Polissacarídeos/administração & dosagem , Polissacarídeos/uso terapêutico , Rubiaceae/química
20.
Eur J Med Res ; 14 Suppl 4: 78-81, 2009 Dec 07.
Artigo em Inglês | MEDLINE | ID: mdl-20156731

RESUMO

Some studies have suggested that the polyphenolic compounds might reduce the occurrence of asthma symptoms. The aim of our experiments was to evaluate the effects of 21 days of the flavonoid Flavin7 administration on experimentally induced airway inflammation in ovalbumin-sensitized guinea pigs. We assessed tracheal smooth muscle reactivity by an in vitro muscle-strip method; changes in airway resistance by an in vivo plethysmographic method; histological picture of tracheal tissue; and the levels of interleukin 4 (IL-4), and interleukin 5 (IL-5) in bronchoalveolar lavage fluid (BALF). Histological investigation of tracheal tissue and the concentrations of the inflammatory cytokines IL-4 and IL-5 in BALF were used as indices of airway inflammation. Administration of Flavin7 caused a significant decrease of specific airway resistance after histamine nebulization and a decline in tracheal smooth muscle contraction amplitude in response to bronchoconstricting mediators. Flavin7 minimized the degree of inflammation estimated on the basis of eosinophil calculation and IL-4 and IL-5 concentrations. In conclusion, administration of Flavin7 showed bronchodilating and anti-inflammatory effects on allergen-induced airway inflammation.


Assuntos
Hiper-Reatividade Brônquica/tratamento farmacológico , Flavonoides/uso terapêutico , Ovalbumina/imunologia , Estilbenos/uso terapêutico , Animais , Hiper-Reatividade Brônquica/imunologia , Citocinas/fisiologia , Cobaias , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...